Hermès outperforms luxury peers with resilient Q1 2025 sales growth, driven by strong demand in the U.S. and Europe.
UnitedHealth's disappointing Q1 earnings and lowered 2025 forecast trigger market losses across health insurers and broader indices.
SpaceX, Palantir, and Anduril are leading contenders to build key elements of Trump's 'Golden Dome' missile defense system, but the project's structure and oversight remain uncertain.
Hermès outperforms luxury peers with resilient Q1 2025 sales growth, driven by strong demand in the U.S. and Europe.
UnitedHealth's disappointing Q1 earnings and lowered 2025 forecast trigger market losses across health insurers and broader indices.
SpaceX, Palantir, and Anduril are leading contenders to build key elements of Trump's 'Golden Dome' missile defense system, but the project's structure and oversight remain uncertain.